Fluid Status and Body Composition Analysis by Bioelectrical Impedance in Patients After Cardiac Surgery (FLUBIACS)

Launched by UNIVERSITY MEDICAL CENTRE LJUBLJANA · Jul 4, 2024

Keywords

ClinConnect Summary

The FLUBIACS trial is a study looking at how fluid levels in patients who have heart surgery affect their recovery. The researchers will use a method called bioelectrical impedance, which is a simple and safe way to measure body fluids and composition. This trial aims to find out if better monitoring of fluid status can help reduce complications and improve outcomes after surgery.

To participate in this study, people need to be at least 18 years old and scheduled for elective heart surgery. They should also be classified as ASA 3 or 4, meaning they have some health issues that could complicate surgery. People with certain conditions, like severe kidney problems or those who have had a limb amputated, will not be eligible to join. If you choose to participate, you will provide both verbal and written consent and will help researchers understand more about how managing fluid levels can positively impact recovery after cardiac surgery.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • 1. Elective cardiovascular surgery (on-pump or off-pump)
• • 2. Age ≥ 18 years
• • 3. ASA 3 or 4
• • 4. Provided verbal and written informed consent
• • Exclusion criteria
• • 1. Refusal to participate in the research
• • 2. \< 18 years
• • 3. Renal failure requiring replacement treatment with hemodialysis
• • 4. Amputation of a limb
• • 5. Pregnancy
• • 6. Emergency Procedures
• • 7. Reoperation
• • 8. Pacemaker/implantable cardioverter-defibrillator